Epirubicin is not superior to doxorubicin in the treatment of advanced soft tissue sarcomas. The experience of the EORTC soft tissue and bone sarcoma group

OS Nielsen; P Dombernowsky; H Mouridsen; S Daugaard; M Glabbeke; A Kirkpatrick; Jaap Verweij

Epirubicin is not superior to doxorubicin in the treatment of advanced soft tissue sarcomas. The experience of the EORTC soft tissue and bone sarcoma group

OS Nielsen
, P Dombernowsky
, H Mouridsen
, S Daugaard
, M Glabbeke
, A Kirkpatrick
, Jaap Verweij

Medical Oncology

External organisation

Research output: Contribution to journal › Article › Academic

31 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	31-35
Number of pages	5
Journal	Sarcoma
Volume	4
Publication status	Published - 2000

Research programs

EMC MM-03-86-08

Cite this

@article{5e8e581bd195492da89839532a02bd28,

title = "Epirubicin is not superior to doxorubicin in the treatment of advanced soft tissue sarcomas. The experience of the EORTC soft tissue and bone sarcoma group",

author = "OS Nielsen and P Dombernowsky and H Mouridsen and S Daugaard and M Glabbeke and A Kirkpatrick and Jaap Verweij",

year = "2000",

language = "Undefined/Unknown",

volume = "4",

pages = "31--35",

journal = "Sarcoma",

issn = "1357-714X",

publisher = "John Wiley \& Sons Ltd.",

}

TY - JOUR

T1 - Epirubicin is not superior to doxorubicin in the treatment of advanced soft tissue sarcomas. The experience of the EORTC soft tissue and bone sarcoma group

AU - Nielsen, OS

AU - Dombernowsky, P

AU - Mouridsen, H

AU - Daugaard, S

AU - Glabbeke, M

AU - Kirkpatrick, A

AU - Verweij, Jaap

PY - 2000

Y1 - 2000

M3 - Article

SN - 1357-714X

VL - 4

SP - 31

EP - 35

JO - Sarcoma

JF - Sarcoma

ER -